Dibucaine Ointment
Product Images NDC 57896-131

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Dibucaine (NDC 57896-131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Geri-care Pharmaceuticals, Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gericare-dibucaine-1oz-cder (Gericare Dibucaine 1oz Cder)

Gericare-dibucaine-1oz-cder (Gericare Dibucaine 1oz Cder)
This is a product for temporary relief of hemorrhoidal pain, itching, and burning. It comes in child-resistant packaging and should only be used externally. The active ingredient is Dibucaine 1%, and the user should not exceed the directed dosage. If symptoms do not subside, or if other symptoms develop, like redness or swelling, the user should discontinue use and contact a doctor. It is advised not to use in or near the eyes, nor on children under 2 years of age. If pregnant, or breastfeeding, seeking medical advice is recommended. This product should be kept out of the reach of children. In case of ingestion, contact poison control immediately. The inactive ingredients include lanolin, light mineral oil, purified water, and white petroleum. The product should be stored at 20-25°C (68-77°F) and should not be used if the foil seal is broken or missing.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.